Want to see SONX full AI Analyst Report?
SONX Stock Chart & Stats
$1.00
$0.00(0.00%)
At close: 4:00 PM EDT
$1.00
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$0.02 - $1.30
Previous CloseN/A
Volume1.00
Average Volume (3M)125.00
Market Cap
$470.14K
Enterprise Value$6.93
Total Cash (Recent Filing)$11.63M
Total Debt (Recent Filing)$18.93M
Price to Earnings (P/E)―
Beta-1.31
Next Earnings
Mar 23, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.36
Shares Outstanding427,401
10 Day Avg. Volume20
30 Day Avg. Volume125
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)-0.62
Price to Sales (P/S)0.05
P/FCF Ratio-0.13
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-46.56
Revenue Forecast (FY)$42.30M
Bulls Say, Bears Say
Bulls Say
Recurring Consumables ModelThe combination of capital equipment and procedure-specific consumables gives Sonendo an installed-base revenue model. As consoles are used more often, recurring disposable sales can grow without requiring an entirely new equipment sale for every procedure, supporting revenue visibility.
Lower Debt BurdenThe substantial reduction in total debt lowers the company’s absolute repayment burden and may reduce financial pressure compared with 2023. If maintained, this improvement can preserve more operating resources for commercialization and product adoption, despite broader balance-sheet weaknesses.
Narrowing Net LossesThe sharp improvement in net losses indicates meaningful progress in cost control and/or product mix. Although Sonendo remains unprofitable, a smaller loss base reduces the amount of capital needed to sustain operations and could provide a foundation for eventual earnings improvement.
Bears Say
Revenue ContractionTwo consecutive years of revenue contraction raise concerns about market adoption, procedure volumes, or the company’s ability to expand its medical-device platform. Shrinking sales also limits operating leverage and makes it harder to support durable profitability from the existing business model.
Negative Stockholders’ EquityNegative equity is a major capitalization weakness because liabilities exceed the book value of assets. This reduces financial flexibility, leaves less balance-sheet cushioning against further operating losses, and may increase dependence on external funding while the company remains unprofitable.
Persistent Cash BurnContinued negative operating and free cash flow means the business has not yet funded itself through operations. Persistent cash consumption can constrain investment in commercialization and require external financing or additional balance-sheet capacity before sustainable positive cash generation is achieved.
Sonendo News
SONX FAQ
What was Sonendo’s price range in the past 12 months?
Sonendo lowest stock price was $0.02 and its highest was $1.30 in the past 12 months.
What is Sonendo’s market cap?
Sonendo’s market cap is $470.14K.
When is Sonendo’s upcoming earnings report date?
Sonendo’s upcoming earnings report date is Mar 23, 2027 which is in 192 days.
How were Sonendo’s earnings last quarter?
Sonendo released its earnings results on Mar 26, 2025. The company reported -$13.35 earnings per share for the quarter, missing the consensus estimate of -$13.04 by -$0.31.
Is Sonendo overvalued?
According to Wall Street analysts Sonendo’s price is currently Overvalued.
Does Sonendo pay dividends?
Sonendo does not currently pay dividends.
What is Sonendo’s EPS estimate?
Sonendo’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Sonendo have?
Sonendo has 427,401 shares outstanding.
What happened to Sonendo’s price movement after its last earnings report?
Sonendo reported an EPS of -$13.35 in its last earnings report, missing expectations of -$13.04. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Sonendo?
Currently, no hedge funds are holding shares in SONX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Sonendo
Sonendo, Inc. operates as a commercial-stage medical technology firm, dedicated to innovating, producing, and marketing advanced devices for root canal treatment across the United States and Canada. A flagship offering is GentleWave, an innovative device for addressing tooth decay that meticulously cleans and sanitizes the intricate microscopic passages within teeth without the need for removing any natural tooth structure. The company's product line also features SoundSeal, a specialized material used to construct and seal dental crowns, alongside its proprietary Sonendo-branded liquid solution of EDTA, which assists in the debridement and disinfection processes crucial for root canal systems. Furthermore, Sonendo provides "The Digital Office," a comprehensive practice management software solution designed to foster an integrated digital environment for dental professionals. Established in 2006, the organization was initially known as Dentatek Corporation before officially rebranding to Sonendo, Inc. in March 2011. Its corporate headquarters are situated in Laguna Hills, California.
Technical Analysis
Ownership Overview
―
Insiders
1.08% Mutual Funds
― Other Institutional Investors
98.92% Public Companies and
Individual Investors